Opportunities and Challenges of Population Pharmacogenomics
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou+3 more
wiley +1 more source
Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study). [PDF]
Montero-Balosa MC+8 more
europepmc +1 more source
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.
S. Schulman+9 more
semanticscholar +1 more source
Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott+3 more
wiley +1 more source
Appropriate target range of INR and predictive factors of recurrent thrombosis and bleeding in patients with venous thromboembolism on warfarin. [PDF]
Sae-Lim P, Saelue P.
europepmc +1 more source
Objectives To evaluate the safety and efficacy of magnetic resonance imaging (MRI)‐guided transurethral ultrasound ablation (TULSA) as a minimally invasive alternative for benign prostatic obstruction (BPO). Patients and Methods This prospective, single‐centre, early phase II study (NCT03350529) included 30 men with BPO scheduled for primary ...
Antti Viitala+9 more
wiley +1 more source
Comparative Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Valvular Atrial Fibrillation: A Systematic Qualitative Review. [PDF]
Chaudhri M+13 more
europepmc +1 more source
Effective stroke prevention in AF requires a comprehensive holistic approach incorporating appropriate risk stratification, guideline‐adherent anticoagulation and management of underlying cardiovascular conditions and other comorbidities. The ABC pathway, supported by characterisation using the 4S‐AF framework, provides a structured approach to ...
Amir Askarinejad+4 more
wiley +1 more source
Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines. [PDF]
Vyas V, Vyas V, Sharma A, Ashok Kumar P.
europepmc +1 more source